Humans Differ from Other Hominids in Lacking an Activating NK Cell Receptor That Recognizes the C1 Epitope of MHC Class I
Open Access
- 1 October 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 185 (7) , 4233-4237
Abstract
Modulation of human NK cell function by killer cell Ig-like receptors (KIR) and MHC class I is dominated by the bipartite interactions of inhibitory lineage III KIR with the C1 and C2 epitopes of HLA-C. In comparison, the ligand specificities and functional contributions of the activating lineage III KIR remain poorly understood. Using a robust, sensitive assay of KIR binding and a representative panel of 95 HLA class I targets, we show that KIR2DS1 binds C2 with ~50% the avidity of KIR2DL1, whereas KIR2DS2, KIR2DS3, and KIR2DS5 have no detectable avidity for C1, C2, or any other HLA class I epitope. In contrast, the chimpanzee has activating C1- and C2-specific lineage III KIR with strong avidity, comparable to those of their paired inhibitory receptors. One variant of chimpanzee Pt–KIR3DS2, the activating C2-specific receptor, has the same avidity for C2 as does inhibitory Pt–KIR3DL4, and a second variant has ~73% the avidity. Chimpanzee Pt–KIR3DS6, the activating C1-specific receptor, has avidity for C1 that is ~70% that of inhibitory Pt–KIR2DL6. In both humans and chimpanzees we observe an evolutionary trend toward reducing the avidity of the activating C1- and C2-specific receptors through selective acquisition of attenuating substitutions. However, the extent of attenuation has been extreme in humans, as exemplified by KIR2DS2, an activating C1-specific receptor that has lost all detectable avidity for HLA class I. Supporting such elimination of activating C1-specific receptors as a uniquely human phenomenon is the presence of a high-avidity activating C1-specific receptor (Gg–KIR2DSa) in gorilla.Keywords
This publication has 28 references indexed in Scilit:
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemiaBlood, 2010
- Coevolution of Killer Cell Ig-Like Receptors with HLA-C To Become the Major Variable Regulators of Human NK CellsThe Journal of Immunology, 2010
- Education of human natural killer cells by activating killer cell immunoglobulin-like receptorsBlood, 2010
- KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-CJournal of Experimental Medicine, 2009
- Chimpanzees Use More Varied Receptors and Ligands Than Humans for Inhibitory Killer Cell Ig-Like Receptor Recognition of the MHC-C1 and MHC-C2 EpitopesThe Journal of Immunology, 2009
- Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemiaBlood, 2009
- The Yin and Yang of HLA and KIR in human diseaseSeminars in Immunology, 2008
- Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the moleculeGenes & Immunity, 2008
- The Counterbalance Theory for Evolution and Function of Paired ReceptorsImmunity, 2008
- MHC class I–specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-responseBlood, 2008